WASHINGTON The Food and Drug Administration on Monday published the names of eight new panelists who will serve on a committee advising the agency on whether to allow compounding pharmacies to manufacture certain peptides
Funding The authors acknowledge the financial support provided by CSIR (Council of Scientific and Industrial Research), New Delhi and UGC-SAP, New Delhi
Patients should be advised to source any compounded products from reputable pharmacies that follow USP sterile compounding standards
Keep out of reach of children under three years of age
The cohort included 82% males and 18% females, and children with genetic syndromes, prematurity, major medical disease or severe irritability were excluded, although common comorbidities such as gastrointestinal, allergic, neurological, and sleep disorders were present